These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

47 related items for PubMed ID: 1319080

  • 1. Mode of action of new quinolones: the inhibitory activity on DNA gyrase.
    Sato K, Hoshino K, Mitsuhashi S.
    Prog Drug Res; 1992; 38():121-32. PubMed ID: 1319080
    [No Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of drug inhibition of DNA gyrase.
    Lewis RJ, Tsai FT, Wigley DB.
    Bioessays; 1996 Aug; 18(8):661-71. PubMed ID: 8760340
    [Abstract] [Full Text] [Related]

  • 3. [Quinolones. Gyrase inhibitors].
    Höffler D.
    Internist (Berl); 1994 May; 35(5):484-9. PubMed ID: 8021119
    [No Abstract] [Full Text] [Related]

  • 4. [New quinolones, current therapies].
    Auckenthaler R.
    Schweiz Rundsch Med Prax; 1988 Nov 08; 77(45):1217-8. PubMed ID: 2847274
    [No Abstract] [Full Text] [Related]

  • 5. Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.
    Marchetto R, Nicolás E, Castillo N, Bacardit J, Navia M, Vila J, Giralt E.
    J Pept Sci; 2001 Jan 08; 7(1):27-40. PubMed ID: 11245203
    [Abstract] [Full Text] [Related]

  • 6. Injured mitochondria in cells of Euglena gracilis after DNA gyrase inhibitors treatment.
    Polónyi J, Ebringer L, Krajcovic J, Kapeller K.
    Z Mikrosk Anat Forsch; 1990 Jan 08; 104(1):61-78. PubMed ID: 2161591
    [Abstract] [Full Text] [Related]

  • 7. [How well do gyrase inhibitors work? The pharmacokinetics of quinolones].
    Sörgel F, Bulitta J, Kinzig-Schippers M.
    Pharm Unserer Zeit; 2001 Jan 08; 30(5):418-27. PubMed ID: 11575179
    [No Abstract] [Full Text] [Related]

  • 8. [Quinolones in the environment: biological breakdown of gyrase inhibitors].
    Wetzstein HG.
    Pharm Unserer Zeit; 2001 Jan 08; 30(5):450-7. PubMed ID: 11575183
    [No Abstract] [Full Text] [Related]

  • 9. [Where are quinolones going? New agents in development].
    Holzgrabe U.
    Pharm Unserer Zeit; 2001 Jan 08; 30(5):446-8. PubMed ID: 11575182
    [No Abstract] [Full Text] [Related]

  • 10. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR, Malik M, Snyder M, Drlica K.
    J Mol Biol; 1996 May 17; 258(4):627-37. PubMed ID: 8636997
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist].
    Schurz JK.
    Pharm Unserer Zeit; 2001 May 17; 30(5):400-5. PubMed ID: 11575176
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. On the mechanism of action of quinolone drugs.
    Palumbo M, Gatto B, Zagotto G, Palù G.
    Trends Microbiol; 1993 Sep 17; 1(6):232-5. PubMed ID: 8137121
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. From fluoroquinolones to 2-pyridones.
    Hooper DC.
    Lancet; 1995 May 13; 345(8959):1192-3. PubMed ID: 7739303
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.